Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
14,68 USD | +4,82 % | +12,64 % | -32,25 % |
12:30 | Sage Therapeutics, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 | CI |
18/04 | SAGE THERAPEUTICS, INC. : Scotiabank reitera su recomendación de compra | ZM |
Resumen de negocios
Número de empleados: 487
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Medicines
100,0
%
| 8 | 100,0 % | 86 | 100,0 % | +1.024,84 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 8 | 100,0 % | 86 | 100,0 % | +1.024,84 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 01/10/20 |
Steven Paul
FOU | Founder | 73 | 16/04/10 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 01/03/13 |
Mike Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/14 |
Laura Gault
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/22 |
Matt Lasmanis
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/20 |
Amy Schacterle
COO | Chief Operating Officer | - | 13/02/15 |
Jeff Jonas
BRD | Director/Board Member | 71 | 14/08/13 |
Tammy J. Phinney
LAW | General Counsel | - | 01/08/20 |
Vanessa Procter
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 14/08/13 |
Steven Paul
FOU | Founder | 73 | 16/04/10 |
Barry Greene
CEO | Chief Executive Officer | 60 | 01/10/20 |
Jim Frates
BRD | Director/Board Member | 56 | 01/05/14 |
Michael Cola
BRD | Director/Board Member | 64 | 11/09/14 |
Geno Germano
CHM | Chairman | 63 | 19/07/16 |
Director/Board Member | 67 | 23/01/19 | |
Director/Board Member | 62 | 23/01/19 | |
Jessica Federer
BRD | Director/Board Member | - | 15/03/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 60 109 720 | 52 558 950 ( 87,44 %) | 3 033 ( 0,005046 %) | 87,44 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-32,25 % | 841 M | |
-3,01 % | 104 mil M | |
+0,63 % | 97,42 mil M | |
+1,28 % | 22,2 mil M | |
-18,03 % | 21,23 mil M | |
-10,51 % | 18,33 mil M | |
-42,33 % | 16,35 mil M | |
-17,89 % | 15,06 mil M | |
+4,84 % | 13,98 mil M | |
+28,19 % | 11,66 mil M |
- Bolsa de valores
- Acciones
- Acción SAGE
- Empresa Sage Therapeutics, Inc.